, Volume 188, Issue 6, pp 505–510 | Cite as

Pleuropericarditis in a Patient with Inflammatory Bowel Disease: A Case Presentation and Review of the Literature

  • Muhanned Abu-HijlehEmail author
  • Samuel Evans
  • Bassam Aswad


Inflammatory bowel disease (IBD) can affect the lung parenchyma and airways. Rarely it involves the pleural space and pericardium, causing inflammatory exudative pleural and/or pericardial effusions. In this report, we describe a 76-year-old patient with recurrent sterile exudative pleuropericarditis that gradually responded to treatment with steroids, and we review the relevant literature. Thoracic serositis in patients with IBD can cause pleuritis, pericarditis, pleuropericarditis, or myopericarditis. This is a relatively rare presentation of the uncommon and probably underreported and underrecognized pulmonary extraintestinal manifestations of IBD. Pleuropericardial inflammatory disease and effusion can be directly related to IBD, its complications, associated infections, or the medications used to treat it. Serositis directly related to IBD is a diagnosis of exclusion. It is important to evaluate the pleural effusion and rule out other etiologies before making this diagnosis. Pleural or pericardial biopsies are rarely necessary, and probably show nonspecific acute and chronic inflammatory changes. Although the specific pathophysiology of pleuropericardial disease in patients with IBD remains unclear, the response to systemic steroids is usually adequate.


Inflammatory bowel disease Pleuritis Pleuro-pericarditis Extra-intestinal manifestations of IBD 


  1. 1.
    Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517CrossRefPubMedGoogle Scholar
  2. 2.
    Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA (2007) The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5(12):1424–1429CrossRefPubMedGoogle Scholar
  3. 3.
    Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39(5):690–697CrossRefPubMedGoogle Scholar
  4. 4.
    Camus P, Piard F, Ashcroft T, Gal AA, Colby TV (1993) The lung in inflammatory bowel disease. Medicine (Baltimore) 72(3):151–183Google Scholar
  5. 5.
    Storch I, Sachar D, Katz S (2003) Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 9(2):104–115CrossRefPubMedGoogle Scholar
  6. 6.
    Casey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV (2003) Noninfectious lung pathology in patients with Crohn’s disease. Am J Surg Pathol 27(2):213–219CrossRefPubMedGoogle Scholar
  7. 7.
    Ekbom A, Brandt L, Granath F, Löfdahl CG, Egesten A (2008) Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD. Lung 186(3):167–172CrossRefPubMedGoogle Scholar
  8. 8.
    Kraft SC, Earle RH, Roesler M, Esterly JR (1976) Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 136(4):454–459CrossRefPubMedGoogle Scholar
  9. 9.
    Patwardhan RV, Heilpern RJ, Brewster AC, Darrah JJ (1983) Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature. Arch Intern Med 143(1):94–96CrossRefPubMedGoogle Scholar
  10. 10.
    Rosenbaum AJ, Murphy PJ, Engel JJ (1983) Pleurisy during the course of ulcerative colitis. J Clin Gastroenterol 5(6):517–521CrossRefPubMedGoogle Scholar
  11. 11.
    Abid MA, Gitlin N (1990) Pericarditis—an extraintestinal complication of inflammatory bowel disease. West J Med 153(3):314–315PubMedGoogle Scholar
  12. 12.
    Bernstein CN, Wajda A, Blanchard JF (2005) The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129(3):827–836CrossRefPubMedGoogle Scholar
  13. 13.
    Black H, Mendoza M, Murin S (2007) Thoracic manifestations of inflammatory bowel disease. Chest 131(2):524–532CrossRefPubMedGoogle Scholar
  14. 14.
    Ho GT, Innes JA, Shand AG, Satsangi J (2006) Bronchopulmonary manifestations of inflammatory bowel disease: a case report and literature review. J R Coll Phys Edin 36:299–303Google Scholar
  15. 15.
    Wallaert B, Colombel JF, Tonnel AB, Bonniere P, Cortot A, Paris JC, Voisin C (1985) Evidence of lymphocyte alveolitis in Crohn’s disease. Chest 87(3):363–367CrossRefPubMedGoogle Scholar
  16. 16.
    Smiéjan JM, Cosnes J, Chollet-Martin S, Soler P, Basset FM, Le Quintrec Y, Hance AJ (1986) Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn’s disease. Ann Intern Med 104(1):17–21PubMedGoogle Scholar
  17. 17.
    Adenis A, Colombel JF, Lecouffe P, Wallaert B, Hecquet B, Marchandise X, Cortot A (1992) Increased pulmonary and intestinal permeability in Crohn’s disease. Gut 33(5):678–682CrossRefPubMedGoogle Scholar
  18. 18.
    Mohammed AR, Babu S (2008) Serositis and inflammatory bowel disease. Br J Hosp Med (Lond) 69(5):296–297Google Scholar
  19. 19.
    Swinburn CR, Jackson GJ, Cobden I, Ashcroft T, Morritt GN, Corris PA (1988) Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. Thorax 43(9):735–736CrossRefPubMedGoogle Scholar
  20. 20.
    Faller M, Gasser B, Massard G, Pauli G, Quoix E (2000) Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn’s disease. Respiration 67(4):459–463CrossRefPubMedGoogle Scholar
  21. 21.
    Haralambou G, Teirstein AS, Gil J, Present DH (2001) Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med 68(6):384–388PubMedGoogle Scholar
  22. 22.
    Parry SD, Barbatzas C, Peel ET, Barton JR (2002) Sulphasalazine and lung toxicity. Eur Respir J 19(4):756–764CrossRefPubMedGoogle Scholar
  23. 23.
    Mukhopadhyay D, Nasr K, Grossman BJ, Kirsner JB (1970) Pericarditis associated with inflammatory bowel disease. JAMA 211(9):1540–1542CrossRefPubMedGoogle Scholar
  24. 24.
    Breitenstein RA, Salel AF, Watson DW (1974) Chronic inflammatory bowel disease: acute pericarditis and pericardial tamponade [letter]. Ann Intern Med 81(3):406PubMedGoogle Scholar
  25. 25.
    Thompson DG, Lennard-Jones JE, Swarbrick ET, Bown R (1979) Pericarditis and inflammatory bowel disease. Q J Med 48(189):93–97PubMedGoogle Scholar
  26. 26.
    Puntis JW, Tarlow MJ, Raafat F, Booth IW (1990) Crohn’s disease of the lung. Arch Dis Child 65(11):1270–1271CrossRefPubMedGoogle Scholar
  27. 27.
    Orii S, Chiba T, Nakadate I, Fujiwara T, Ito N, Ishii M, Oana S, Chida T, Kudara N, Terui T, Yamaguchi T, Suzuki K (2001) Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis. J Clin Gastroenterol 32(3):251–254CrossRefPubMedGoogle Scholar
  28. 28.
    Stajer D, Gorjup V (1996) Myopericarditis, pleuritis and deep venous thrombosis in ulcerative colitis masquerading as pulmonary embolism. Intensive Care Med 22(10):1134–1135CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Muhanned Abu-Hijleh
    • 1
    Email author
  • Samuel Evans
    • 2
  • Bassam Aswad
    • 3
  1. 1.Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Rhode Island HospitalThe Alpert Medical School of Brown UniversityProvidenceUSA
  2. 2.Department of Medicine, Internal Medicine Residency Program, Rhode Island HospitalThe Alpert Medical School of Brown UniversityProvidenceUSA
  3. 3.Department of Pathology, Rhode Island HospitalThe Alpert Medical School of Brown UniversityProvidenceUSA

Personalised recommendations